Prostate cancer: Diagnostic performance of the PCA3 urine test

George Leighton Lee, Albert Dobi*, Shiv Srivastava

*Corresponding author for this work

Research output: Contribution to journalShort surveypeer-review

157 Scopus citations


The potential of the prostate cancer antigen 3 (PCA3) urine assay to aid prostate cancer diagnosis and minimize unnecessary biopsies has been extensively studied. Results from three recent studies that compared the performance of PCA3 with PSA underscore the advancement and future challenges for this new diagnostic biomarker.

Original languageEnglish
Pages (from-to)123-124
Number of pages2
JournalNature Reviews Urology
Issue number3
StatePublished - Apr 2011
Externally publishedYes


Dive into the research topics of 'Prostate cancer: Diagnostic performance of the PCA3 urine test'. Together they form a unique fingerprint.

Cite this